Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study hopes to outsmart pancreatic cancer by gathering clues

NCT ID NCT05692596

Ongoing Knowledge-focused Sponsor: H. Lee Moffitt Cancer Center and Research Institute Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study collects health information and test results from 317 people at high risk for pancreatic cancer, including those with cysts, genetic syndromes, or other risk factors. Researchers aim to build a database to find better ways to detect the disease early or prevent it. No new treatments are being tested; instead, the focus is on learning from existing patient data.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to better ways to detect pancreatic cancer early or prevent it, potentially saving lives.

What could go wrong

This is an observational study, not a treatment trial, so it won't directly benefit participants. Results may take years and might not lead to immediate clinical changes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ataxia telangiectasia chronic pancreatitis classic familial adenomatous polyposis Colorectal Neoplasms, Hereditary Nonpolyposis familial atypical multiple mole melanoma syndrome hereditary chronic pancreatitis Lynch syndrome melanoma, cutaneous malignant, susceptibility to, 2 PALB2-related cancer predisposition Pancreatic Cyst pancreatic ductal adenocarcinoma Peutz-Jeghers syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATAXIA TELANGIECTASIA BRCA MUTATION CHRONIC PANCREATITIS FAMILIAL ATYPICAL MULTIPLE MOLE-MELANOMA FAP FATTY PANCREAS GENETIC PANCREATIC CANCER GENETIC PANCREATITIS LYNCH SYNDROME PALB2 GENE MUTATION PANCREATIC CYST PANCREATIC DUCTAL ADENOCARCINOMA PEUTZ-JEGHERS SYNDROME

Contacts and locations

Locations

  • Moffitt Cancer Center

    Tampa, Florida, 33617, United States